HUP0402024A3 - Solid composition containing bacillus-type non-pathogenic bacterial spores - Google Patents

Solid composition containing bacillus-type non-pathogenic bacterial spores

Info

Publication number
HUP0402024A3
HUP0402024A3 HU0402024A HUP0402024A HUP0402024A3 HU P0402024 A3 HUP0402024 A3 HU P0402024A3 HU 0402024 A HU0402024 A HU 0402024A HU P0402024 A HUP0402024 A HU P0402024A HU P0402024 A3 HUP0402024 A3 HU P0402024A3
Authority
HU
Hungary
Prior art keywords
composition containing
solid composition
type non
bacterial spores
pathogenic bacterial
Prior art date
Application number
HU0402024A
Other languages
English (en)
Original Assignee
Sanofi Synthelabo Otc S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo Otc S P A filed Critical Sanofi Synthelabo Otc S P A
Publication of HUP0402024A2 publication Critical patent/HUP0402024A2/hu
Publication of HUP0402024A3 publication Critical patent/HUP0402024A3/hu
Publication of HU229652B1 publication Critical patent/HU229652B1/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/742Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1611Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pretreatment Of Seeds And Plants (AREA)
HU0402024A 2001-07-27 2002-07-26 Solid composition containing bacillus-type non-pathogenic bacterial spores HU229652B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2001MI001632A ITMI20011632A1 (it) 2001-07-27 2001-07-27 Composizione solida contenente spore di batteri non patogeni del genere bacillus
PCT/EP2002/008384 WO2003011341A1 (fr) 2001-07-27 2002-07-26 Composition solide contenant des spores de bacteries non pathogenes du genre bacillus

Publications (3)

Publication Number Publication Date
HUP0402024A2 HUP0402024A2 (hu) 2005-01-28
HUP0402024A3 true HUP0402024A3 (en) 2005-06-28
HU229652B1 HU229652B1 (en) 2014-03-28

Family

ID=11448170

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0402024A HU229652B1 (en) 2001-07-27 2002-07-26 Solid composition containing bacillus-type non-pathogenic bacterial spores

Country Status (32)

Country Link
US (2) US8039006B2 (hu)
EP (1) EP1429808B1 (hu)
JP (1) JP4913986B2 (hu)
KR (2) KR20090099022A (hu)
CN (1) CN1323720C (hu)
AT (1) ATE462448T1 (hu)
AU (1) AU2002333278B2 (hu)
BR (1) BRPI0211453B1 (hu)
CA (1) CA2454389C (hu)
CO (1) CO5560587A2 (hu)
CY (1) CY1112608T1 (hu)
DE (1) DE60235819D1 (hu)
DK (1) DK1429808T3 (hu)
EA (1) EA006847B1 (hu)
ES (1) ES2356325T3 (hu)
GE (2) GEP20053721B (hu)
HK (1) HK1061644A1 (hu)
HR (1) HRP20040066B1 (hu)
HU (1) HU229652B1 (hu)
IL (2) IL159807A0 (hu)
IT (1) ITMI20011632A1 (hu)
MA (1) MA27051A1 (hu)
MX (1) MXPA04000835A (hu)
NO (1) NO332656B1 (hu)
NZ (1) NZ530743A (hu)
PL (1) PL209647B1 (hu)
PT (1) PT1429808E (hu)
SI (1) SI1429808T1 (hu)
TN (1) TNSN04018A1 (hu)
UA (1) UA81225C2 (hu)
WO (1) WO2003011341A1 (hu)
ZA (1) ZA200400440B (hu)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6599631B2 (en) 2001-01-26 2003-07-29 Nanogram Corporation Polymer-inorganic particle composites
KR100931948B1 (ko) * 2007-06-26 2009-12-15 영남대학교 산학협력단 제올라이트를 이용한 바실러스 포자의 열 안정성 향상 방법
BE1018018A6 (nl) 2008-02-28 2010-04-06 Gielen Cornelis Oplossing voor het biologisch reinigen van tandenborstels en bijhorende inrichting.
US9560852B2 (en) 2008-04-07 2017-02-07 Bayer Intellectual Property Gmbh Combinations of biological control agents and insecticides or fungicides
CN101990398A (zh) * 2008-04-07 2011-03-23 拜耳作物科学有限公司 稳定的含有孢子的水性制剂
IT1393931B1 (it) * 2009-02-25 2012-05-17 Neuroscienze Pharmaness S C A R L Composizione di spore di batteri non patogeni
WO2011120530A1 (en) * 2010-03-31 2011-10-06 Lifecycle Phama A/S Porous tablets as carriers for liquid formulations
PT3628161T (pt) * 2012-11-23 2023-05-15 Seres Therapeutics Inc Composições bacterianas sinergísticas e métodos de produção e utilização das mesmas
US8906668B2 (en) 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
EP2951283A4 (en) 2013-02-04 2017-01-25 Seres Therapeutics, Inc. Compositions and methods
US11185562B2 (en) 2013-02-04 2021-11-30 Seres Therapeutics, Inc. Compositions and methods for inhibition of pathogenic bacterial growth
AU2014232370B2 (en) 2013-03-15 2018-11-01 Seres Therapeutics, Inc. Network-based microbial compositions and methods
CN116370507A (zh) 2013-11-25 2023-07-04 赛里斯治疗公司 协同细菌组合物以及其制造方法和用途
WO2015095241A2 (en) 2013-12-16 2015-06-25 Seres Health, Inc. Bacterial compositions and methods of use thereof for treatment of immune system disorders
CA3072206A1 (en) 2017-08-14 2019-02-21 Seres Therapeutics, Inc. Compositions and methods for treating cholestatic disease
US11278578B2 (en) * 2018-09-02 2022-03-22 Sanzyme Biologics Private Limited Combination probiotic compositions and uses thereof
FR3125945A1 (fr) * 2021-08-03 2023-02-10 Setalg Composition pour protéger un microorganisme dans un environnement acide.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1061894A (en) * 1963-03-01 1967-03-15 Lucien Nouvel Therapeutically active bacterial preparations
GB8425487D0 (en) * 1984-10-09 1984-11-14 Agricultural Genetics Co Strain of bacillus thuringiensis
DE3707160A1 (de) 1987-03-06 1988-09-15 Hoechst Ag Bacillus polymyxa enthaltende mittel zur verabreichung an tiere
JPH0761255B2 (ja) * 1990-10-31 1995-07-05 旭化成工業株式会社 安定化芽胞形成生菌製剤の製造法
DE4404702A1 (de) 1994-02-15 1995-08-31 Hoechst Schering Agrevo Gmbh Wasserdispergierbare Granulate auf der Basis lebender Organismen
EP0746310B1 (en) * 1994-02-23 1998-11-18 BM Research A/S Controlled release composition
AU697456B2 (en) * 1994-06-15 1998-10-08 Dumex-Alpharma A/S Pellets
DE4442255A1 (de) 1994-11-28 1996-05-30 Bayer Ag Schädlingsbekämpfungsmittel
JP3180886B2 (ja) * 1995-06-07 2001-06-25 旭化成株式会社 動物成長促進剤
JP5108174B2 (ja) * 1998-04-01 2012-12-26 ガネデン バイオテック, インコーポレイテッド Bacilluscoagulans芽胞を用いてコレステロールを低減させるための方法、系、および組成物
US6924133B1 (en) * 1999-10-01 2005-08-02 Novozymes A/S Spray dried enzyme product
US6387874B1 (en) * 2001-06-27 2002-05-14 Spartan Chemical Company, Inc. Cleaning composition containing an organic acid and a spore forming microbial composition

Also Published As

Publication number Publication date
CA2454389C (fr) 2011-07-12
MXPA04000835A (es) 2004-05-14
US8039006B2 (en) 2011-10-18
NZ530743A (en) 2005-08-26
CA2454389A1 (fr) 2003-02-13
SI1429808T1 (sl) 2010-11-30
HK1061644A1 (en) 2004-09-30
NO332656B1 (no) 2012-11-26
ATE462448T1 (de) 2010-04-15
GEP20053721B (en) 2006-01-10
KR20090099022A (ko) 2009-09-18
US8551498B2 (en) 2013-10-08
CY1112608T1 (el) 2016-02-10
KR100970787B1 (ko) 2010-07-16
US20040241772A1 (en) 2004-12-02
PL209647B1 (pl) 2011-09-30
PT1429808E (pt) 2010-06-23
EP1429808B1 (fr) 2010-03-31
ITMI20011632A1 (it) 2003-01-27
US20120009167A1 (en) 2012-01-12
CN1323720C (zh) 2007-07-04
HRP20040066B1 (en) 2012-02-29
WO2003011341A1 (fr) 2003-02-13
IL159807A0 (en) 2004-06-20
UA81225C2 (en) 2007-12-25
CO5560587A2 (es) 2005-09-30
HUP0402024A2 (hu) 2005-01-28
AU2002333278B2 (en) 2007-05-31
KR20040032868A (ko) 2004-04-17
ES2356325T3 (es) 2011-04-07
EA006847B1 (ru) 2006-04-28
PL366984A1 (en) 2005-02-07
EA200400072A1 (ru) 2004-08-26
NO20040347L (no) 2004-03-26
BRPI0211453B1 (pt) 2018-04-03
HRP20040066A2 (en) 2004-06-30
CN1558776A (zh) 2004-12-29
ITMI20011632A0 (it) 2001-07-27
TNSN04018A1 (fr) 2006-06-01
EP1429808A1 (fr) 2004-06-23
GEP20063721B (en) 2006-01-10
DK1429808T3 (da) 2010-07-19
ZA200400440B (en) 2005-03-30
DE60235819D1 (de) 2010-05-12
HU229652B1 (en) 2014-03-28
JP2004538311A (ja) 2004-12-24
BR0211453A (pt) 2004-08-17
IL159807A (en) 2010-05-31
JP4913986B2 (ja) 2012-04-11
MA27051A1 (fr) 2004-12-20

Similar Documents

Publication Publication Date Title
HUP0301745A3 (en) Cyclopentanoindoles, compositions containing such compounds and their use
MXPA03007093A (es) Nueva composicion.
AU2002354251A1 (en) Bactericidal composition
HUP0402024A3 (en) Solid composition containing bacillus-type non-pathogenic bacterial spores
AU2002333278A1 (en) Solid composition containing Bacillus-type non-pathogenic bacterial spores
MXPA03009698A (es) Vacuna multivalente que comprende un antigeno vih y un antigeno vsh y/o un antigeno vph.
MXPA03007693A (es) Composicion para la piel.
EP1450610A4 (en) PROBIOTIC COMPOSITIONS
GB0114069D0 (en) Composition
EG23378A (en) Composition.
HK1059576A1 (en) Powdery composition
AU2002357356A1 (en) Novel antifungal bacterium and compositions
GB0122113D0 (en) Composition
EP1364646A4 (en) FENOFIBRATE CONTAINING COMPOSITION
MXPA03008077A (es) Composicion humedecedora para la piel..
GB0115679D0 (en) Composition
GB0117305D0 (en) Composition
IL162223A0 (en) 1,3-Diarylprop-2-en-1-ones, compositions containing same and use thereof
GB0126081D0 (en) Composition
GB0121454D0 (en) Composition
MXPA03006632A (es) Composicion solida.
GB0126085D0 (en) Composition
GB0120137D0 (en) Bacterial agglutinant
AU2001229610A1 (en) Anti-foam composition
GB0103771D0 (en) Sealing composition